Clinical trial
A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome…
NCT00097591 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00097591 |
|---|---|
| Title | A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention |
| Official title | A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Daiichi Sankyo Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Arteriosclerosis, Acute Coronary Syndromes |
| Intervention type | Drug |
| Interventions | Prasugrel, Clopidogrel |
| Enrollment | 13,619 |
| Start date | Nov 1, 2004 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Nov 25, 2004 |
| Last update posted | Sep 16, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: